Ordered by composite index (descending). Higher values indicate more intensive citation.
| # | Reference | Year | Mentions | Breadth | Sec. Wtd | Share | Composite | Main % |
|---|---|---|---|---|---|---|---|---|
| 1 | Wu CF | 1981 | 8 | 4 | 15.0 | 0.022 | 1.000 | 100% |
| 2 | Lindley DV | 1956 | 3 | 3 | 6.0 | 0.008 | 0.843 | 100% |
| 3 | Fedorov VV | 2013 | 3 | 3 | 6.0 | 0.008 | 0.843 | 100% |
| 4 | Pukelsheim F | 2006 | 3 | 3 | 6.0 | 0.008 | 0.843 | 100% |
| 5 | Silvey S | 2013 | 3 | 3 | 6.0 | 0.008 | 0.843 | 100% |
| 6 | Titterington D | 1975 | 3 | 3 | 6.0 | 0.008 | 0.843 | 100% |
| 7 | Rigollet P, Hutter JC | 2019 | 3 | 3 | 6.0 | 0.008 | 0.843 | 100% |
| 8 | Ding P | 2023 | 4 | 2 | 8.0 | 0.011 | 0.811 | 100% |
| 9 | Bai Y | 2022 | 4 | 2 | 8.0 | 0.011 | 0.811 | 100% |
| 10 | Cochran W, Autrey K, Cannon C | 1941 | 3 | 2 | 4.0 | 0.008 | 0.737 | 100% |
| 11 | Imbens GW, Rubin DB | 2015 | 3 | 2 | 6.0 | 0.008 | 0.737 | 100% |
| 12 | Bhat N, Farias VF, Moallemi CC, Sinha D | 2020 | 3 | 2 | 6.0 | 0.008 | 0.737 | 100% |
| 13 | Bojinov I, Shephard N | 2019 | 3 | 2 | 6.0 | 0.008 | 0.737 | 100% |
| 14 | Chamandy N | 2016 | 2 | 2 | 3.0 | 0.006 | 0.644 | 100% |
| 15 | Huang S, Wang C, Yuan Y, Zhao J, Zhang J | 2023 | 2 | 2 | 3.0 | 0.006 | 0.644 | 100% |
| 16 | Tang Y, Huang C, Kastelman D, Bauman J | 2020 | 2 | 2 | 3.0 | 0.006 | 0.644 | 100% |
| 17 | Bickel PJ, Doksum KA | 2015 | 2 | 2 | 3.0 | 0.006 | 0.644 | 100% |
| 18 | Casella G, Berger RL | 2002 | 2 | 2 | 3.0 | 0.006 | 0.644 | 100% |
| 19 | Savage LJ | 1951 | 2 | 2 | 4.0 | 0.006 | 0.644 | 100% |
| 20 | Atkinson A, Donev A, Tobias R | 2007 | 2 | 2 | 4.0 | 0.006 | 0.644 | 100% |
| 21 | Atkinson AC, Fedorov VV | 1975 | 2 | 2 | 4.0 | 0.006 | 0.644 | 100% |
| 22 | Card D, Krueger AB | 1993 | 2 | 2 | 4.0 | 0.006 | 0.644 | 100% |
| 23 | Kasy M | 2016 | 2 | 2 | 4.0 | 0.006 | 0.644 | 100% |
| 24 | Wager S | 2020 | 2 | 2 | 4.0 | 0.006 | 0.644 | 100% |
| 25 | Buhlmann P, van de Geer S | 2011 | 2 | 2 | 4.0 | 0.006 | 0.644 | 100% |
| 26 | Wainwright MJ | 2019 | 2 | 2 | 4.0 | 0.006 | 0.644 | 100% |
| 27 | Rubin DB | 1978 | 2 | 2 | 3.0 | 0.006 | 0.644 | 100% |
| 28 | Basse GW, Ding Y, Toulis P | 2023 | 2 | 2 | 4.0 | 0.006 | 0.644 | 100% |
| 29 | Bojinov I, Simchi-Levi D, Zhao J | 2023 | 2 | 2 | 4.0 | 0.006 | 0.644 | 100% |
| 30 | Zhao J | 2023 | 2 | 2 | 4.0 | 0.006 | 0.644 | 100% |
| 31 | Kallus N | 2018 | 2 | 2 | 4.0 | 0.006 | 0.644 | 100% |
| 32 | Xiong R, Athey S, Bayati M, Imbens G | 2023 | 2 | 2 | 4.0 | 0.006 | 0.644 | 100% |
| 33 | Hu F, Rosenberger WF | 2006 | 2 | 2 | 4.0 | 0.006 | 0.644 | 100% |
| 34 | Hu Y, Wager S | 2022 | 3 | 1 | 6.0 | 0.008 | 0.585 | 100% |
| 35 | Shin J, Ramdas A, Rinaldo A | 3 | 1 | 6.0 | 0.008 | 0.585 | 100% | |
| 36 | Zhan R, Ren Z, Athey S, Zhou Z | 2023 | 3 | 1 | 6.0 | 0.008 | 0.585 | 100% |
| 37 | Zhang K, Janson L, Murphy S | 2020 | 3 | 1 | 6.0 | 0.008 | 0.585 | 100% |
| 38 | Farronato C, MacCormack A, Mehta S | 2018 | 2 | 1 | 2.0 | 0.006 | 0.511 | 100% |
| 39 | Sibson R | 1974 | 2 | 1 | 4.0 | 0.006 | 0.511 | 100% |
| 40 | Manski CF | 2013 | 2 | 1 | 4.0 | 0.006 | 0.511 | 100% |
| 41 | Leung MP | 2 | 1 | 4.0 | 0.006 | 0.511 | 100% | |
| 42 | Si N | 2023 | 2 | 1 | 4.0 | 0.006 | 0.511 | 100% |
| 43 | Liang T, Recht B | 2023 | 2 | 1 | 4.0 | 0.006 | 0.511 | 100% |
| 44 | Glynn PW, Johari R, Rasouli M | 2020 | 2 | 1 | 4.0 | 0.006 | 0.511 | 100% |
| 45 | Jia S, Bhattacharya S, Kallus N, Yu CL | 2023 | 2 | 1 | 4.0 | 0.006 | 0.511 | 100% |
| 46 | Farias V, Li A, Peng T, Zheng A | 2022 | 2 | 1 | 4.0 | 0.006 | 0.511 | 100% |
| 47 | Athey S, Chetty R, Imbens GW, Kang H | 2019 | 2 | 1 | 4.0 | 0.006 | 0.511 | 100% |
| 48 | Atkinson AC | 1982 | 2 | 1 | 4.0 | 0.006 | 0.511 | 100% |
| 49 | Bowden J, Trippa L | 2017 | 2 | 1 | 4.0 | 0.006 | 0.511 | 100% |
| 50 | Dimakopoulou M, Ren Z, Zhou Z | 2021 | 2 | 1 | 4.0 | 0.006 | 0.511 | 100% |
| 51 | Hadad V, Hirshberg DA, Zhan R, Wager S, Athey S | 2021 | 2 | 1 | 4.0 | 0.006 | 0.511 | 100% |
| 52 | Zhan R, Hadad V, Hirshberg DA, Athey S | 2021 | 2 | 1 | 4.0 | 0.006 | 0.511 | 100% |
| 53 | Zhang K, Janson L, Murphy S | 2021 | 2 | 1 | 4.0 | 0.006 | 0.511 | 100% |
| 54 | Qin C, Russo D | 2024 | 2 | 1 | 4.0 | 0.006 | 0.511 | 100% |
| 55 | Landovitz RJ, Donnell D, Clement ME, Hanscom B, Co... | 2021 | 1 | 1 | 1.0 | 0.003 | 0.406 | 100% |
| 56 | He Q, Gao F, Dukes O, Delany-Moretlwe S, Zhang B | 2024 | 1 | 1 | 1.0 | 0.003 | 0.406 | 100% |
| 57 | Maruthi B, Joseph RV | 1999 | 1 | 1 | 1.0 | 0.003 | 0.406 | 100% |
| 58 | Mosteller F | 1995 | 1 | 1 | 1.0 | 0.003 | 0.406 | 100% |
| 59 | Koning R, Hasan S, Chatterji A | 2022 | 1 | 1 | 1.0 | 0.003 | 0.406 | 100% |
| 60 | Chen G, Lu C, Chan T, Qi Z, Zhang D, Jin Y, Yang M | 2024 | 1 | 1 | 1.0 | 0.003 | 0.406 | 100% |
| 61 | Farias V, Li H, Peng T, Ren X, Zhang H, Zheng A | 2023 | 1 | 1 | 1.0 | 0.003 | 0.406 | 100% |
| 62 | Gupta S, Kohavi R, Tang D, Xu Y, Andersen R, Baksh... | 2019 | 1 | 1 | 1.0 | 0.003 | 0.406 | 100% |
| 63 | Ye Z, Zhang Z, Zhang D, Zhang H, Zhang RP | 1 | 1 | 1.0 | 0.003 | 0.406 | 100% | |
| 64 | Zhu Z, Cai Z, Zheng L, Si N | 2024 | 1 | 1 | 1.0 | 0.003 | 0.406 | 100% |
| 65 | Kohavi R, Deng A, Frasca B, Walker T, Xu Y, Pohlma... | 2013 | 1 | 1 | 1.0 | 0.003 | 0.406 | 100% |
| 66 | Tang D, Agarwal A, O'Brien D, Meyer M | 2010 | 1 | 1 | 1.0 | 0.003 | 0.406 | 100% |
| 67 | Neyman J, Pearson ES | 1933 | 1 | 1 | 1.0 | 0.003 | 0.406 | 100% |
| 68 | Wald A | 1949 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 69 | Chaloner KM | 1982 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 70 | Chaloner K, Verdinelli I | 1995 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 71 | Letham B, Karrer B, Ottoni G, Bakshy E | 2019 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 72 | Lindley DV | 1972 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 73 | Hernan MA, Robins JM | 2010 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 74 | Rosenbaum PR, Rosenbaum P, Briskman | 2010 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 75 | Pearl J, et al | 2000 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 76 | Pearl J, Glymour M, Jewell NP | 2016 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 77 | Peters J, Janzing D, Scholkopf B | 2017 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 78 | Spirtes P, Glymour C, Scheines R | 2001 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 79 | Ben-Tal A, El Ghaoui L, Nemirovski A | 2009 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 80 | Bertsekas DP | 1997 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 81 | Bertsimas D, Tsitsiklis JN | 1997 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 82 | Birge JR, Louveaux F | 2011 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 83 | Boyd SP, Vandenberghe L | 2004 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 84 | Nocedal J, Wright SJ | 1999 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 85 | Schrijver A, et al | 2003 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 86 | Berger JO | 2013 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 87 | Chen X, Jasin S, Shi C | 2022 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 88 | Wooldridge JM | 2010 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 89 | Neyman J | 1923 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 90 | Holland PW | 1986 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 91 | Rubin DB | 1974 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 92 | Athey S, Imbens GW | 2017 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 93 | Holland PW | 1988 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 94 | Cox DR | 1958 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 95 | Rubin D | 1980 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 96 | Rubin DB | 2005 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 97 | Abadie A, Athey S, Imbens GW, Wooldridge JM | 2020 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 98 | Manski CF, Pepper JV | 2018 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 99 | Wolfowitz J | 1952 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 100 | Good P | 2013 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 101 | Bai Y | 2023 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 102 | Candogan O, Chen C, Niazadeh R | 2023 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 103 | Ni T, Bojinov I, Zhao J | 2023 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 104 | Manski CF | 2004 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 105 | Stoye J | 2009 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 106 | Tibshirani R | 1996 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 107 | Smith K | 1918 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 108 | Goemans MX, Williamson DP | 1995 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 109 | Allen-Zhu Z, Li Y, Singh A, Wang Y | 2021 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 110 | Madan V, Singh M, Tantipongpipat U, Xie W | 2019 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 111 | Meyer RK, Nachtsheim CJ | 1995 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 112 | Nikolov A | 2015 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 113 | Nikolov A, Singh M | 2016 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 114 | Singh M, Xie W | 2018 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 115 | Singh M, Xie W | 2020 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 116 | Summa MD, Eisenbrand F, Faenza Y, Moldenhauer C | 2014 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 117 | Abadie A | 2021 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 118 | Abadie A, Diamond A, Hainmueller J | 2010 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 119 | Abadie A, Gardeazabal J | 2003 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 120 | Doudchenko N, Gilinson D, Taylor S, Wernerfelt N | 2019 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 121 | Doudchenko N, Khosravi K, Pouget-Abadie J, Lahaie ... | 2021 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 122 | Lu Y, Li J, Ying L, Blanchet J | 2022 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 123 | Abadie A, Zhao J | 2021 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 124 | Hudgens MG, Halloran ME | 2008 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 125 | Tchetgen Tchetgen EJ, VanderWeele TJ | 2012 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 126 | Aronow PM, Samii C | 2017 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 127 | Athey S, Eckles D, Imbens GW | 2018 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 128 | Li S, Wager S | 2022 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 129 | Belloni A, Fang F, Volfovsky A | 2022 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 130 | Leung MP | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% | |
| 131 | Savje F, Aronow P, Hudgens M | 2021 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 132 | Yu CL, Airoldi EM, Borgs C, Chayes JT | 2022 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 133 | Yuan Y, Altenburger K, Kooti F | 2021 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 134 | Yuan Y, Altenburger KM | 2023 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 135 | Boyarsky A, Namkoong H, Pouget-Abadie J | 2023 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 136 | Cortez-Rodriguez M, Eichhorn M, Yu CL | 2024 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 137 | Han K, Li S, Mao J, Wu H | 2022 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 138 | Bajari P, Burdick B, Imbens GW, Masoero L, McQueen... | 2021 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 139 | Munro E, Wager S, Xu K | 2021 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 140 | Munro E | 2024 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 141 | Wager S, Xu K | 2021 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 142 | Basse GW, Soufiani HA, Lambert D | 2016 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 143 | Bright I, Delarue A, Lobel I | 2022 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 144 | Dhaouadi W, Johari R, Weintraub GY | 2023 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 145 | Johari R, Li H, Liskovich I, Weintraub GY | 2022 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 146 | Kuang X, Mendelson G | 2024 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 147 | Liao L, Kroer C | 2023 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 148 | Li H, Zhao G, Johari R, Weintraub GY | 2022 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 149 | Li S, Johari R, Kuang X, Wager S | 2023 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 150 | Si N, Gultekin S, Blanchet J, Flores A | 2023 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 151 | Ye Z, Zhang DJ, Zhang H, Zhang R, Chen X, Xu Z | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% | |
| 152 | Goli A, Lambrecht A, Yoganarasimhan H | 2023 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 153 | Holtz D, Brennan J, Pouget-Abadie J | 2023 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 154 | Johnson GA, Lewis RA, Nubbemeyer EI | 2017 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 155 | Zhan R, Han S, Hu Y, Jiang Z | 2024 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 156 | Kastelman D, Ramesh R | 2018 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 157 | Chen H, Simchi-Levi D | 2023 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 158 | Xiong R, Chin A, Taylor SJ | 2024 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 159 | Prentice RL | 1989 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 160 | Wen Q, Shi C, Yang Y, Tang N, Zhu H | 2024 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 161 | Yang J, Eckles D, Dhillon P, Aral S | 2023 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 162 | Hohnhold H, O'Brien D, Tang D | 2015 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 163 | Munro E, Jones D, Brennan J, Nelet R, Mirrokni V, ... | 2023 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 164 | Cochran WG, Cox GM | 1948 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 165 | Cox DR, Reid N | 2000 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 166 | Rubin DB | 2008 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 167 | Cytrynbaum M | 2021 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 168 | Greevy R, Lu B, Silber JH, Rosenbaum P | 2004 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 169 | Higgins MJ, Savje F, Sekhon JS | 2016 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 170 | Lu B, Greevy R, Xu X, Beck C | 2011 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 171 | Tabord-Meehan M | 2023 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 172 | Deng A, Xu Y, Kohavi R, Walker T | 2013 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 173 | Jin Y, Ba S | 2023 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 174 | Wu Y, Zheng Z, Zhang G, Zhang Z, Wang C | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% | |
| 175 | Abadie A, Imbens GW | 2012 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 176 | Abadie A, Imbens GW | 2006 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 177 | Bertsimas D, Johnson M, Kallus N | 2015 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 178 | Dehejia RH, Wahba S | 2002 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 179 | Diamond A, Sekhon JS | 2013 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 180 | Hirano K, Imbens GW, Ridder G | 2003 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 181 | Imai K, King G, Nall C | 2009 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 182 | Rosenbaum PR, Rubin DB | 1983 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 183 | Rosenbaum PR, Rubin DB | 1984 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 184 | Rosenbaum PR | 1989 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 185 | Zubizarreta JR | 2012 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 186 | Alexanderian A, Petra N, Stadler G, Ghattas O | 2014 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 187 | De Castro Y, Gamboa F, Henrion D, Hess R, Lasserre... | 2019 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 188 | Ruan Y, Yang J, Zhou Y | 2021 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 189 | Uci\'nski D, Bogacka B | 2005 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 190 | Ahmadi AA, Parrilo PA | 2012 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 191 | Helmberg C | 2002 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 192 | Luo ZQ, Ma WK, So AMC, Ye Y, Zhang S | 2010 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 193 | Nie J | 2014 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 194 | Parrilo PA | 2003 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 195 | Todd MJ | 2001 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 196 | Vandenberghe L, Boyd S | 1996 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 197 | Chattopadhyay A, Morris CN, Zubizarreta JR | 2022 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 198 | Harshaw C, Savje F, Spielman DA, Zhang P | 2024 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 199 | Li JQ, Rusmevichientong P, Simester D, Tsitsiklis ... | 2015 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 200 | Morris C, et al | 1979 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 201 | Brown CA, Lilford RJ | 2006 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 202 | Hemming K, Haines TP, Chilton PJ, Girling AJ, Lilf... | 2015 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 203 | Hussey MA, Hughes JP | 2007 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 204 | Li F, Turner EL, Preisser JS | 2018 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 205 | Efron B | 1971 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 206 | Pocock SJ, Simon R | 1975 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 207 | Atkinson AC | 1999 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 208 | Bertsimas D, Korolko N, Weinstein AM | 2019 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 209 | Kapelner A, Krieger A | 2014 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 210 | Rosenberger WF, Sverdlov O | 2008 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 211 | Rosenberger WF, Lachin JM | 2015 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 212 | Zhao J, Zhou Z | 2024 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 213 | Murphy SA | 2005 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 214 | Offer-Westort M, Coppock A, Green DP | 2021 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 215 | Deshpande Y, Mackey L, Syrgkanis V, Taddy M | 2018 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 216 | Hirano K, Porter JR | 2023 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 217 | Nie X, Tian X, Taylor J, Zou J | 2018 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 218 | Shin J, Ramdas A, Rinaldo A | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% | |
| 219 | Asmussen S, Glynn PW | 2007 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 220 | Glasserman P | 2004 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 221 | Ross SM | 2013 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 222 | Ham DW, Bojinov I, Lindon M, Tingley M | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% | |
| 223 | Ham DW, Lindon M, Tingley M, Bojinov I | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% | |
| 224 | Abbasi-Yadkori Y, Bartlett P, Gabillon V, Malek A,... | 2018 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 225 | Adusumilli K | 2022 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 226 | Audibert JY, Bubeck S | 2010 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 227 | Bubeck S, Munos R, Stoltz G | 2009 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 228 | Chen J, Chen X, Zhang Q, Zhou Y | 2017 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 229 | Chen X, Gopi S, Mao J, Schneider J | 2018 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 230 | Chen X, Liu Q, Wang Y | 2023 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 231 | Kasy M, Sautmann A | 2021 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 232 | Kato M, Ariu K, Imaizumi M, Uehara M, Nomura M, Qi... | 2022 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 233 | Mannor S, Tsitsiklis JN | 2004 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 234 | Miao R, Qi Z, Shi C, Lin L | 2023 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 235 | Naby AD, Farajollahzadeh S, Hu M | 2024 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 236 | Qin C, Klabjan D, Russo D | 2017 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 237 | Qin C | 2022 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 238 | Russo D | 2016 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 239 | Tang J, Qi Z, Fang E, Shi C | 2022 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 240 | Xu J, Wu Y, Wang Y, Wang C, Zheng Z | 2023 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 241 | Wu Y, Zheng Z, Zhang G, Zhang Z, Wang C | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% | |
| 242 | Zhang Z, Zeng Z, Zhan R, Zhang DJ | 2024 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 243 | Zhou Y, Chen X, Li J | 2014 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 244 | Antos A, Grover V, Szepesvari C | 2010 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 245 | Armstrong TB | 2022 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 246 | Aznag A, Cummings R, Elmachtoub AN | 2024 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 247 | Blackwell M, Pashley NE, Valentino D | 2022 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 248 | Carpentier A, Munos R | 2011 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 249 | Carpentier A, Lazaric A, Ghavamzadeh M, Munos R, A... | 2011 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 250 | Carpentier A, Munos R | 2012 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 251 | Carpentier A, Munos R, Antos A | 2015 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 252 | Dai J, Gradu P, Harshaw C | 2024 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 253 | Deep V, Bassamboo A, Juneja S | 2023 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 254 | Fontaine X, Perrault P, Valko M, Perchet V | 2021 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 255 | Grover V | 2009 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 256 | Hahn J, Hirano K, Karlan D | 2011 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 257 | Russac Y, Katsimerou C, Bohle D, Cappe O, Garivier... | 2021 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 258 | Wei W, Ma X, Wang J | 2023 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 259 | Wei W, Ma X, Wang J | 2024 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 260 | Athey S, Byambadalai U, Hadad V, Krishnamurthy SK,... | 2022 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 261 | Bui L, Johari R, Mannor S | 2011 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 262 | Drugan MM, Nowe A | 2013 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 263 | Erraqabi A, Lazaric A, Valko M, Brunskill E, Liu Y... | 2017 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 264 | Krishnamurthy SK, Zhan R, Athey S, Brunskill E | 2024 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 265 | Simchi-Levi D, Wang C | 2023 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 266 | Yao J, Brunskill E, Pan W, Murphy S, Doshi-Velez F | 2021 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 267 | Zhong Z, Cheung WC, Tan VY | 2021 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 268 | Siegmund D | 2013 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 269 | Wald A | 2004 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 270 | Bibaut A, Kallus N, Lindon M | 2022 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 271 | Cho B, Gan K, Kallus N | 2024 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 272 | Jamieson KG, Jain L | 2018 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 273 | Johari R, Pekelis L, Walsh DJ | 2015 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 274 | Johari R, Koomen P, Pekelis L, Walsh D | 2017 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 275 | Lindon M, Ham DW, Tingley M, Bojinov I | 2022 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 276 | Liang B, Bojinov I | 2023 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 277 | Malenica I, Guo Y, Gan K, Konigorski S | 2023 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 278 | Ramdas A, Ruf J, Larsson M, Koolen W | 2020 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |
| 279 | Ramdas A, Grunwald P, Vovk V, Shafer G | 2023 | 1 | 1 | 2.0 | 0.003 | 0.406 | 100% |